Suraksha Diagnostic Ltd Share Price

Diagnostic ServicesNSE
₹311.50
-18.40-5.58% (1D)
As on 20 Nov 2026 at 15:59
As of 20 Nov 2026 at 15:59, Suraksha Diagnostic Ltd is trading at ₹311.50. The 52-week range stands at ₹224.10–₹384.00, with a market cap of ₹1.62 thousand crore. At a P/E of 38.03 and a dividend yield of 0.02%, it is a small-cap stock in the Healthcare sector.

SURAKSHA Price Chart

Market Cap
₹1.62K Cr
PE Ratio
38.03
ROCE
16.28%

Suraksha Diagnostic Ltd Performance

Suraksha Diagnostic Ltd Fundamentals

Know More
Market Cap₹1.62K Cr
ROE15.38%
P/E Ratio (TTM)38.03
EPS (TTM)₹8.20
P/B Ratio5.85
Dividend Yield0.02%
Industry P/E188.26
Book Value₹53.33
Debt to Equity0.55
Face Value₹2

Suraksha Diagnostic Ltd Shareholding Pattern

Know More
Promoter49.1%
Foreign Institutions14%
Mutual Funds20.2%
Domestic Institutions1.4%
Public15.4%

Suraksha Diagnostic Ltd Financial Statements

Know More
No data for this view.

Suraksha Diagnostic Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Apollo Hospitals Enterprise Ltd
₹9,190.05
452.05(+5.17%)
1,32,138.86,696.5 - 9,282.5
Max Healthcare Institute Ltd
₹1,079.60
38.95(+3.74%)
1,05,080.4797.0 - 1,185.4
Manipal Health Enterprises Ltd
₹702.20
5.75(+0.83%)
92,365.8597.0 - 815.0
Aster DM Quality Care Ltd
₹779.65
40.35(+5.46%)
67,959.9519.1 - 891.3
Fortis Healthcare Ltd
₹825.00
15.15(+1.87%)
62,284.1705.0 - 1,010.1

About Suraksha Diagnostic

Suraksha Diagnostic Limited was initially incorporated as Suraksha Diagnostic Private Limited' as a private limited company dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal. Subsequently, Company was converted into a Public Limited company named Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Central Processing Centre. The Company is mainly engaged in running diagnostic centres for carrying out various pathological and radiological testing and medical consultation services in in East India. In addition to integrated pathology and radiology testing services, it also offer omnichannel medical consultation services via online and offline modes to customers through 43 of its diagnostic centres which house 120 polyclinic chambers hosting 750+ doctors. The diagnostic test menu included (a) 788 routine pathology tests ranging from basic biochemistry and hematology to 647 specialized pathology tests such as advanced biochemistry, histopathology, and molecular pathology, and (b) 748 basic/intermediate radiology tests ranging from basic x-rays, ultrasonography (USG), and computerized tomography (CT) scans to 104 advanced radiology tests such as magnetic resonance imaging (MRI) scans and specialized CT scans. The diagnostic centre was initially operated under the Group Company, Suraksha Diagnostic and Eye Centre Private Limited, which was later acquired by the Company in 2005. The first centre of the Company was launched at Kestopur in 2007. The second centre launched at Khardah in 2010, which increased the operating centres to 5. The Company increased the laboratories to 4 and the operating centres rose to 25 in 2016. The Company further acquired the business of Sunwell Diagnostic Private Limited in 2017. The operations to Meghalaya were expanded through a public-private partnership with the Government of Meghalaya in 2019. Further, 2 pre-existing diagnostic centres in Kolkata were acquired by the Company from Future Medical and Research Trust in 2020. And the first 3T MRI and 128 CT launched at New Town in 2023. The Company launched the IPO by raising Rs 846.25 Crore equity shares with the issuance of 19,189,330 equity shares of face value of Rs 2 through offer for sale in December, 2024. The Company added 7 new centres to the network under the Public Private Partnership (PPP) model. With these additions, the network grew to 55 centres as of March, 2025. In FY 2026, the Company acquired Fetomat Wellness Private Limited having 63% equity stake. It launched Suraksha Genomics marked as technology-enabled patient services. The diagnostic centres increased to 68 across the Northeastern India in 2026.

Parent Organisation—
Founded2005
Managing DirectorRitu Mittal
NSE SymbolSURAKSHA

Suraksha Diagnostic Ltd Resistance and Support levels

R3356.77R2348.97R1344.16S1328.57S2323.76S3315.97311.50

Suraksha Diagnostic Ltd Technicals

Current Price
₹311.50 ₹18.40 (-5.58%)
Bearish
9
Bullish
3
  • 20 Day6.9%
  • 50 Day4.4%
  • 100 Day0.8%
  • 200 Day2.7%

Suraksha Diagnostic Ltd Latest News

View More
05 NOV 2026 | Thursday
Suraksha Diagnostic to review financial results at board meeting on November 10, 2026
14 OCT 2026 | Wednesday
Suraksha Diagnostic appoints Shreya Arora as Company Secretary, effective October 2026
05 OCT 2026 | Monday
Suraksha Diagnostic reported securities dematerialization details to BSE and NSE
28 SEPT 2026 | Monday
Suraksha Diagnostic's trading window will close October 1, 2026, pending financial results
04 AUG 2026 | Tuesday
Suraksha Diagnostic to review quarterly results at board meeting on August 12, 2026
22 MAY 2026 | Friday
Suraksha Diagnostic AGM scheduled
22 MAY 2026 | Friday
Board of Suraksha Diagnostic recommends final dividend
22 MAY 2026 | Friday
Suraksha Diagnostic Ltd Falls 7.95%

2026

Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Annual ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial

Frequently asked questions

The share price of Suraksha Diagnostic Ltd is ₹311.50 as of 20 Nov 2026 at 15:59.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now